Align Technology reported fourth-quarter EPS of $3.29, exceeding the Street’s $2.99 consensus by $0.30, driven by 5.3% year-over-year revenue growth to $1.05 billion. Clear Aligner volume rose 7.7% year-over-year to 676,855 cases, supported by broad strength across EMEA, Latin America and APAC markets. Return on equity reached 15.32% and net margin improved to 10.17%, compared with 2.44 EPS in the same period last year.

Six research firms have upgraded their thesis on Align this week. Leerink Partners and Mizuho each raised their price targets by 7%–8%, both to outperform ratings, while UBS boosted its target by 5.7% and maintained a neutral stance. Robert W. Baird introduced a $218 target, and Needham & Company reaffirmed its hold rating. The consensus price objective now stands near $193, while the consensus recommendation remains a hold.

Hedge funds and other large investors collectively hold 88.43% of Align’s shares. In the fourth quarter, Gabelli Funds raised its position by 62.5%, adding 4,000 shares; Canada Post Corp Registered Pension Plan grew its stake by 38% with an additional 360 shares; and Northwestern Mutual Wealth Management dramatically boosted its holdings by 35,514%, adding 544,072 shares to reach over 545,600 shares. New positions were opened by GABELLI & Co and North Dakota State Investment Board, each deploying over $250,000.

Align’s 50-day simple moving average stands at $162.45, above its 200-day average of $148.78, signaling positive momentum. The company’s P/E ratio of 31.03 and P/E/G of 1.81 suggest moderate valuation relative to growth prospects. With a market cap north of $12 billion and beta at 1.84, the stock offers exposure to a leading digital‐orthodontics franchise benefiting from secular shift toward clear aligner solutions.